Gosselies, Belgium, 7 May 2019, 7am CEST – BONE THERAPEUTICS (Euronext Brussels and Paris: BOTHE), the bone cell therapy company addressing high unmet medical needs in orthopaedics and bone diseases, today provides a business update for the first quarter ended 31 March 2019. Thomas Lienard, Chief Executive Officer of Bone Therapeutics commented: “We are well-positioned to support long …